European Medicines Agency Approves Pediatric Development Plan for Sargramostim
The European Medicines Agency has endorsed a new Paediatric Investigation Plan for the drug sargramostim. This regulatory action establishes a framework for developing the medicine to ensure its appropriate and safe application in pediatric patients. It aims to guide future studies for this specific medication.
Want more?
Open NewsSnap.ai for the full app experience, including audio, personalization, and more news tools.